Literature DB >> 8322485

Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection.

F Schödel1, G Neckermann, D Peterson, K Fuchs, S Fuller, H Will, M Roggendorf.   

Abstract

Woodchucks were immunized with recombinant woodchuck hepatitis virus (WHV) nucleocapsid antigen (WHcAg) or hepatitis B virus (HBV) nucleocapsid antigen (HBcAg) and challenged with 10(6) WHV ID50. Six out of six woodchucks immunized with WHcAg and four out of six immunized with HBcAg were protected from WHV infection. Woodchucks immunized with WHcAg or HBcAg developed high serum antibody titres against WHcAg or HBcAg. Antibodies against WHc and HBc displayed little cross-reactivity (< 1%). This confirms and extends previous reports of protection against homologous challenge after immunization with HBcAg/WHcAg which are both internal viral antigens. As the dominant B-cell epitope(s) on particulate WHcAg and HBcAg appear not to be conserved it also demonstrates that antibodies against HBcAg/WHcAg are not important for this protection. Woodchucks immunized with WHcAg/HBcAg reacted with a fast serum antibody response against viral envelope proteins upon challenge with WHV, indicative of functional intrastructural/intermolecular T-cell help as one potential mechanism of protection after immunization with an internal viral antigen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322485     DOI: 10.1016/0264-410x(93)90307-j

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Comparative antigenicity and immunogenicity of hepadnavirus core proteins.

Authors:  Jean-Noel Billaud; Darrell Peterson; Florian Schödel; Antony Chen; Matti Sallberg; Fermin Garduno; Phillip Goldstein; Wendy McDowell; Janice Hughes; Joyce Jones; David Milich
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 2.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial.

Authors:  Giane A Oliveira; Kristiane Wetzel; J Mauricio Calvo-Calle; Ruth Nussenzweig; Annette Schmidt; Ashley Birkett; Filip Dubovsky; Eveline Tierney; Christoph H Gleiter; Gabriele Boehmer; Adrian J F Luty; Michael Ramharter; George B Thornton; Peter G Kremsner; Elizabeth H Nardin
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope.

Authors:  S Menne; J Maschke; T K Tolle; M Lu; M Roggendorf
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12.

Authors:  R García-Navarro; B Blanco-Urgoiti; P Berraondo; R Sánchez de la Rosa; A Vales; S Hervás-Stubbs; J J Lasarte; F Borrás; J Ruiz; J Prieto
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge.

Authors:  S Menne; J Maschke; M Lu; H Grosse-Wilde; M Roggendorf
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.

Authors:  F Schödel; S M Kelly; D L Peterson; D R Milich; R Curtiss
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.

Authors:  M Lu; G Hilken; J Kruppenbacher; T Kemper; R Schirmbeck; J Reimann; M Roggendorf
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide.

Authors:  Ina Frank; Claudia Budde; Melanie Fiedler; Uta Dahmen; Sergei Viazov; Mengji Lu; Ulf Dittmer; Michael Roggendorf
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.